Connect with us
Moderna’s vaccine was 94% effective in preventing disease in late stage clinical trials London: Britain’s medical regulator on Friday approved Moderna’s COVID-19 vaccine for use, the...
“We are excited to see 90% efficacy from the half dose-full dose regimen,” an Astra spokesman said. A Covid-19 vaccine developed by the University of Oxford...
Analysis gives detail on how the vaccine provokes strong immune response: Experts (Representational) London: The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British...
Britain’s Oxford University said on Monday initial findings from a study on the long term impact of COVID-19 has found that a large number of patients...
The UK’s National Health Service is preparing for mass vaccination (Representational) London: A vaccine against coronavirus, being developed together by scientists at the University of Oxford...
